Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arrowhead Pharmaceuticals (ARWR) Other Non-Current Liabilities (2016 - 2025)

Arrowhead Pharmaceuticals' Other Non-Current Liabilities history spans 12 years, with the latest figure at $375.0 million for Q4 2025.

  • For Q4 2025, Other Non-Current Liabilities rose 8.14% year-over-year to $375.0 million; the TTM value through Dec 2025 reached $375.0 million, up 8.14%, while the annual FY2025 figure was $367.4 million, 7.63% up from the prior year.
  • Other Non-Current Liabilities reached $375.0 million in Q4 2025 per ARWR's latest filing, up from $367.4 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $375.0 million in Q4 2025 to a low of $252.8 million in Q4 2022.
  • Average Other Non-Current Liabilities over 4 years is $313.5 million, with a median of $336.0 million recorded in 2024.
  • Peak YoY movement for Other Non-Current Liabilities: increased 27.74% in 2024, then increased 7.21% in 2025.
  • A 4-year view of Other Non-Current Liabilities shows it stood at $252.8 million in 2022, then rose by 8.24% to $273.7 million in 2023, then increased by 26.7% to $346.8 million in 2024, then grew by 8.14% to $375.0 million in 2025.
  • Per Business Quant, the three most recent readings for ARWR's Other Non-Current Liabilities are $375.0 million (Q4 2025), $367.4 million (Q3 2025), and $360.3 million (Q2 2025).